Artificial intelligence is transforming nearly every industry these days, and in biopharma that goes for every part of the business -- from research and development to marketing and communi
The COVID-19 pandemic accelerated a change that was already underway with regards to the digitisation of biopharma marketing – and the increasing ubiquity of omnichannel.
In a new pharmaphorum podcast, web editor Nicole Raleigh spoke with Michael Ibara, chief data officer at Elligo Health Research, discussing AI in clinical research and its overall impact on